<p>Black gold staining of corpus callosum (a) and cortex (b) from cuprizone mice, untreated (n = 6) or treated with vehicle (n = 9) or 30 mg/kg GSK247246 (n = 7) for 9 days prior to sacrifice(scale bar = 100 μm); p-values were generated by unpaired Student’s t-Test; (c) representative immunofluorescence image showing GST-π (red) and DAPI (blue) staining in the corpus callosum, untreated (n = 6) or treated with vehicle (n = 9) or 30 mg/kg GSK247246 (n = 7) for 9 days prior to sacrifice (scale bar = 300 μm); p-values were generated by one-way ANOVA with post-hoc Bonferroni's multiple comparisons test (F = 14.59); (d) representative immunofluorescence image showing PDGFRα (green) staining in the corpus callosum, untreated (n = 6) or treated wi...
Figure S1. Time course of cuprizone induced pathology in corpus callosum and cortex. (a) Representat...
BACKGROUND:In the cuprizone model of multiple sclerosis, de- and remyelination can be studied withou...
A central question in demyelinating diseases is how to reverse these conditions and prevent relapse ...
A) The myelin staining (blue) was strongest in the healthy controls (A1). The cuprizone mice that re...
<p>Luxol fast blue (LFB) staining is shown in N+Veh (A), N+P (B), CPZ+Veh (C) and CPZ+P mice (D). (E...
<p><b>A–F</b> Wild-type and Gas6 KO mice were subjected to cuprizone challenge for 5 weeks followed ...
<p>Relative to untreated mice (A) there is demyelination of the corpus callosum of mice fed cuprizon...
<p>T<sub>2</sub>-w RARE coronal images and pathologic sections stained with Black Gold II for myelin...
<p>Cuprizone treatment for 5- or 12-weeks causes a massive decrease in myelination as determined by ...
<p>(<b>A–B</b>) Representative light micrographs of sagittal sections of brain from control and cupr...
A) Experimental study design indicates 0.2% cuprizone administration schedule and MBP staining at we...
<p>SMI32 and APP immunostaining of corpus callosum sections from mice treated for 14 days with PBS (...
Guglielmetti C., Praet J., Vreys R., Rangarajan J.R., Maes F., Verhoye M., Ponsaerts P., Van der Lin...
<p>(A–B) Immunostaining of BrdU-Olig2 (A) and GFAP (B) of the midline corpus callosum of the infused...
The transcriptome of punched out corpus callosum was examined at 4 time points in the cuprizone (CPZ...
Figure S1. Time course of cuprizone induced pathology in corpus callosum and cortex. (a) Representat...
BACKGROUND:In the cuprizone model of multiple sclerosis, de- and remyelination can be studied withou...
A central question in demyelinating diseases is how to reverse these conditions and prevent relapse ...
A) The myelin staining (blue) was strongest in the healthy controls (A1). The cuprizone mice that re...
<p>Luxol fast blue (LFB) staining is shown in N+Veh (A), N+P (B), CPZ+Veh (C) and CPZ+P mice (D). (E...
<p><b>A–F</b> Wild-type and Gas6 KO mice were subjected to cuprizone challenge for 5 weeks followed ...
<p>Relative to untreated mice (A) there is demyelination of the corpus callosum of mice fed cuprizon...
<p>T<sub>2</sub>-w RARE coronal images and pathologic sections stained with Black Gold II for myelin...
<p>Cuprizone treatment for 5- or 12-weeks causes a massive decrease in myelination as determined by ...
<p>(<b>A–B</b>) Representative light micrographs of sagittal sections of brain from control and cupr...
A) Experimental study design indicates 0.2% cuprizone administration schedule and MBP staining at we...
<p>SMI32 and APP immunostaining of corpus callosum sections from mice treated for 14 days with PBS (...
Guglielmetti C., Praet J., Vreys R., Rangarajan J.R., Maes F., Verhoye M., Ponsaerts P., Van der Lin...
<p>(A–B) Immunostaining of BrdU-Olig2 (A) and GFAP (B) of the midline corpus callosum of the infused...
The transcriptome of punched out corpus callosum was examined at 4 time points in the cuprizone (CPZ...
Figure S1. Time course of cuprizone induced pathology in corpus callosum and cortex. (a) Representat...
BACKGROUND:In the cuprizone model of multiple sclerosis, de- and remyelination can be studied withou...
A central question in demyelinating diseases is how to reverse these conditions and prevent relapse ...